This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 12 | 2,613,670 | 4,140,675 | -800,000 | 255,875 | 301,000 | 2,416,912 | 2,541,454 | 2,613,670 | 4,330,549 | 5,498,371 | 5,671,055 | 8,829,763 | 15,306,060 |
| Global health | 12 | 2,613,670 | 4,140,675 | -800,000 | 255,875 | 301,000 | 2,416,912 | 2,541,454 | 2,613,670 | 4,330,549 | 5,498,371 | 5,671,055 | 8,829,763 | 15,306,060 |
| Donor | Total | 2017 | 2016 | 2014 | 2013 | 2012 | 2010 | 2009 | 2006 |
|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 49,688,097.00 | 255,875.00 | 1,741,454.00 | 4,330,549.00 | 2,613,670.00 | 13,970,063.00 | 5,498,371.00 | 5,671,055.00 | 15,607,060.00 |
| Total | 49,688,097.00 | 255,875.00 | 1,741,454.00 | 4,330,549.00 | 2,613,670.00 | 13,970,063.00 | 5,498,371.00 | 5,671,055.00 | 15,607,060.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 12) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 255,875.00 | 11 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to evaluate novel diagnostic platforms that could inform heath authorities on the current burden of infections, as well as on emerging infections and potential outbreaks; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,541,454.00 | 8 | Global health/infectious disease control | https://iatiregistry.org/publisher/bmgf | -- | to evaluate novel diagnostic platforms that could inform heath authorities on the current burden of infections, as well as on emerging infections and potential outbreaks; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -800,000.00 | 12 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop improved vaccines against HIV/AIDS for use throughout the world, in particular in high disease burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,330,549.00 | 5 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop new potential therapeutic agents and inform on the best strategy to generate protective responses induced by vaccination; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,613,670.00 | 7 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to further develop the DNA/NYVAC HIV Vaccine platform. Development of the DNA/NYVAC Platform for HIV Vaccine (PVRD). Investment start date: 11/17/2009 to end date: 9/30/2020. Grantee name: Centre Hospitalier Universitaire Vaudois; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,723,388.00 | 6 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to further develop the DNA/NYVAC HIV Vaccine platform. Development of the DNA/NYVAC Platform for HIV Vaccine (PVRD). Investment start date: 11/17/2009 to end date: 9/30/2020. Grantee name: Centre Hospitalier Universitaire Vaudois; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 2,416,912.00 | 9 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop one potential vaccine strategy that may contribute to the global effort of stopping the HIV pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 8,829,763.00 | 2 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop improved vaccines against HIV/AIDS for use throughout the world, in particular in high disease burden countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,498,371.00 | 4 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop one potential vaccine strategy that may contribute to the global effort of stopping the HIV pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 5,671,055.00 | 3 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to further develop the DNA/NYVAC HIV Vaccine platform. Development of the DNA/NYVAC Platform for HIV Vaccine (PVRD). Investment start date: 11/17/2009 to end date: 9/30/2020. Grantee name: Centre Hospitalier Universitaire Vaudois; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 301,000.00 | 10 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop one potential vaccine strategy that may contribute to the global effort of stopping the HIV pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 15,306,060.00 | 1 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to develop one potential vaccine strategy that may contribute to the global effort of stopping the HIV pandemic; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. |